Biopharmaceutical company Merck & Co., Inc. (MRK) reported Thursday that third-quarter net income attributable to the company increased to $4.57 billion or $1.80 per share from $2.32 billion or $0.92 per share in the prior-year quarter.
from RTT - Earnings https://ift.tt/3mnmnAN
via IFTTT
No comments:
Post a Comment